首页> 美国卫生研究院文献>Oncology Letters >miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1
【2h】

miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1

机译:miR-222在上皮性卵巢癌中上调并通过下调P27kip1促进细胞增殖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Epithelial ovarian cancer (EOC) is the leading cause of female reproductive system cancer mortality in females. The majority of cases of ovarian carcinomas are not identified until a late stage. Identifying the molecular changes that occur during the development and progression of ovarian cancer is an urgent requirement. MicroRNAs (miRNAs) have been identified as gene expression regulators that induce mRNA degradation or translation blockade through pairing to the 3′ untranslated region (3-‘UTR) of the target mRNAs. In the present study, miR-222 was observed to be frequently upregulated in ovarian cancer. miR-222 upregulation induced an enhancement of ovarian cancer cell proliferation potential, possibly by downregulating its target, P27Kip1. A bioinformatic analysis showed that the 3′-UTR of the P27Kip1 mRNA contained a highly-conserved putative miR-222 binding site. Luciferase reporter assays demonstrated that P27Kip1 was a direct target of miR-222. Consistently, there was an inverse correlation between the P27Kip1 and miR-222 expression levels in the ovarian cancer cell lines and tissues. Overall, the present results suggest that miR-222 upregulation in human ovarian cancer may promote ovarian cancer cell proliferation during ovarian carcinogenesis.
机译:上皮性卵巢癌(EOC)是女性女性生殖系统癌症死亡率的主要原因。直到晚期才发现大多数卵巢癌病例。鉴定在卵巢癌发生和发展过程中发生的分子变化是当务之急。 MicroRNA(miRNA)已被鉴定为基因表达调节剂,可通过与目标mRNA的3'非翻译区(3-’UTR)配对来诱导mRNA降解或翻译阻断。在本研究中,观察到miR-222在卵巢癌中经常被上调。 miR-222上调可能通过下调其靶标P27 Kip1 来诱导卵巢癌细胞增殖潜能的增强。生物信息学分析表明,P27 Kip1 mRNA的3'-UTR包含高度保守的推定miR-222结合位点。萤光素酶报告基因检测证明P27 Kip1 是miR-222的直接靶标。一致地,卵巢癌细胞系和组织中的P27 Kip1 和miR-222表达水平呈负相关。总体而言,目前的结果表明,人类卵巢癌中的miR-222上调可能会促进卵巢癌发生过程中卵巢癌细胞的增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号